In a filing, Crinetics Pharmaceuticals Inc revealed its Chief Scientific Officer Betz Stephen F. unloaded Company’s shares for reported $0.14 million on May 28 ’24. In the deal valued at $47.49 per share,3,000 shares were sold. As a result of this transaction, Betz Stephen F. now holds 86,643 shares worth roughly $3.9 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Betz Stephen F. sold 3,000 shares, generating $148,290 in total proceeds. Upon selling the shares at $49.43, the Chief Scientific Officer now owns 89,643 shares.
Before that, Struthers Richard Scott sold 107,448 shares. Crinetics Pharmaceuticals Inc shares valued at $5,307,931 were divested by the President & CEO at a price of $49.40 per share. As a result of the transaction, Struthers Richard Scott now holds 257,485 shares, worth roughly $11.59 million.
Citigroup initiated its Crinetics Pharmaceuticals Inc [CRNX] rating to a Buy in a research note published on March 06, 2024; the price target was $68. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who began to cover the stock in mid January with a ‘”an Overweight”‘ rating. Jefferies began covering CRNX with “Hold” recommendation on December 21, 2023.
Price Performance Review of CRNX
On Monday, Crinetics Pharmaceuticals Inc [NASDAQ:CRNX] saw its stock jump 0.67% to $45.01. Over the last five days, the stock has lost -2.74%. Crinetics Pharmaceuticals Inc shares have risen nearly 26.50% since the year began. Nevertheless, the stocks have risen 104.96% over the past one year. While a 52-week high of $53.70 was reached on 05/22/24, a 52-week low of $15.76 was recorded on 01/05/24. SMA at 50 days reached $46.50, while 200 days put it at $36.31. A total of 0.64 million shares were traded, compared to the trading of 0.67 million shares in the previous session.
Levels Of Support And Resistance For CRNX Stock
The 24-hour chart illustrates a support level at 44.08, which if violated will result in even more drops to 43.14. On the upside, there is a resistance level at 45.52. A further resistance level may holdings at 46.02. The Relative Strength Index (RSI) on the 14-day chart is 43.36, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.60, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 86.47%. Stochastics %K at 12.79% indicates the stock is a buying.
